Bank Of New York Mellon Corp Enzo Biochem Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$1.0 - $2.51 $26,217 - $65,804	26,217 New	26,217 $63.7 Million
Q4 2022 Feb 14, 2023	BUY	$1.16 - $2.42 $30,411 - $63,445	26,217 New	26,217 $37,000
Q3 2022 Nov 14, 2022	BUY	$2.1 - $2.73 $4,195 - $5,454	1,998 Added 2.34%	87,281 $194,000
Q2 2022 Aug 15, 2022	SELL	$2.0 - $3.0 $9,750 - $14,625	-4,875 Reduced 5.41%	85,283 $176,000
Q1 2022 May 11, 2022	BUY	$2.9 - $3.47 $15,451 - $18,488	5,328 Added 6.28%	90,158 $261,000
Q4 2021 Feb 11, 2022	BUY	$3.17 - $4.09 $182,344 - $235,264	57,522 Added 210.64%	84,830 $273,000
Q2 2021 Aug 11, 2021	SELL	$2.86 - $3.61 $364,086 - $459,563	-127,303 Reduced 82.34%	27,308 $86,000
Q1 2021 May 13, 2021	BUY	$2.61 - $4.08 $1,782 - $2,786	683 Added 0.44%	154,611 $531,000
Q4 2020 Feb 09, 2021	SELL	$1.82 - $2.61 $16,261 - $23,320	-8,935 Reduced 5.49%	153,928 $387,000
Q3 2020 Nov 12, 2020	SELL	$2.02 - $3.02 $129,789 - $194,041	-64,252 Reduced 28.29%	162,863 $343,000
Q2 2020 Aug 12, 2020	BUY	$2.12 - $3.22 $2 - $3	1 Added 0.0%	227,115 $508,000
Q1 2020 May 06, 2020	SELL	$1.82 - $3.87 $21,619 - $45,971	-11,879 Reduced 4.97%	227,114 $574,000
Q4 2019 Feb 14, 2020	SELL	$2.57 - $3.68 $5,391 - $7,720	-2,098 Reduced 0.87%	238,993 $628,000
Q3 2019 Nov 07, 2019	SELL	$3.01 - $4.0 $24,092 - $32,016	-8,004 Reduced 3.21%	241,091 $867,000
Q2 2019 Aug 12, 2019	BUY	$2.79 - $4.31 $70,316 - $108,624	25,203 Added 11.26%	249,095 $839,000
Q1 2019 May 14, 2019	BUY	$2.54 - $4.02 $12,633 - $19,995	4,974 Added 2.27%	223,892 $611,000
Q4 2018 Feb 11, 2019	BUY	$2.46 - $4.2 $30,432 - $51,958	12,371 Added 5.99%	218,918 $609,000
Q3 2018 Nov 09, 2018	SELL	$3.81 - $5.53 $3 - $5	-1 Reduced -0.0%	206,547 $0
Q2 2018 Aug 06, 2018	SELL	$5.06 - $6.78 $66,199 - $88,702	-13,083 Reduced 5.96%	206,548 $1.07 Million
Q1 2018 May 15, 2018	BUY	$5.43 - $8.36 $32,829 - $50,544	6,046 Added 2.83%	219,631 $1.2 Million
Q4 2017 Feb 09, 2018	BUY	$8.15 - $10.55 $1.74 Million - $2.25 Million	213,585	213,585 $1.74 Million

Others Institutions Holding ENZ

# of Institutions

Shares Held

15.5M

Call Options Held

2.3K

Put Options Held

Harbert Fund Advisors, Inc. Birmingham, AL

5.18M
Shares

$3.52 Million
3.43% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.53M
Shares

$1.72 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.88M
Shares

$1.28 Million
0.0% of portfolio
Potomac Capital Management, Inc.

1.48M
Shares

$1.01 Million
3.63% of portfolio
Viex Capital Advisors, LLC Sunny Isles Beach, FL

1.33M
Shares

$907,445
9.62% of portfolio

View Full List

About ENZO BIOCHEM INC

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $33.1M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

More about ENZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account